| 股號 / 名稱 | 現金及約當現金 | 流動資產 | 總資產 |
| EDIT Editas Medicine Inc | 123,652,000.0 | 340,829,000.0 | 499,153,000.0 |
| CTKB Cytek Biosciences Inc | 167,299,000.0 | 392,060,000.0 | 494,457,000.0 |
| VRDN Viridian Therapeutics Inc | 102,827,000.0 | 486,478,000.0 | 490,424,000.0 |
| CGEM Cullinan Therapeutics Inc | 98,434,000.0 | 480,191,000.0 | 484,182,000.0 |
| KOD Kodiak Sciences Inc | 285,507,000.0 | 289,309,000.0 | 479,372,000.0 |
| RVNC Revance Therapeutics Inc | 137,329,000.0 | 338,865,000.0 | 478,454,000.0 |
| MNKD MannKind Corp | 238,480,000.0 | 373,393,000.0 | 475,198,000.0 |
| DCPH Deciphera Pharmaceuticals Inc | 83,507,000.0 | 381,096,000.0 | 473,566,000.0 |
| STRO Sutro Biopharma Inc | 69,268,000.0 | 421,542,000.0 | 470,736,000.0 |
| TRDA Entrada Therapeutics Inc | 67,602,000.0 | 369,771,000.0 | 469,192,000.0 |
| CLDX Celldex Therapeutics Inc | 34,814,000.0 | 431,693,000.0 | 465,627,000.0 |
| MRUS Merus NV | 204,246,000.0 | 368,814,000.0 | 455,494,000.0 |
| CDMO Avid Bioservices Inc | 30,708,000.0 | 103,589,000.0 | 455,227,000.0 |
| CSTL Castle Biosciences Inc | 98,841,000.0 | 295,635,000.0 | 453,340,000.0 |
| ANAB AnaptysBio Inc | 35,965,000.0 | 406,835,000.0 | 452,389,000.0 |
| KURA Kura Oncology Inc | 37,318,000.0 | 432,481,000.0 | 448,935,000.0 |
| SEER Seer Inc | 32,499,000.0 | 330,513,000.0 | 436,269,000.0 |
| CRBU Caribou Biosciences Inc | 51,162,000.0 | 338,841,000.0 | 432,209,000.0 |
| ARCT Arcturus Therapeutics Holdings Inc | 292,005,000.0 | 386,590,000.0 | 429,402,000.0 |
| IGMS IGM Biosciences Inc | 112,520,000.0 | 347,597,000.0 | 423,411,000.0 |
| SANG Sangoma Technologies Corp | 10,562,000.0 | 56,541,000.0 | 418,782,000.0 |
| PHAT Phathom Pharmaceuticals Inc | 381,393,000.0 | 397,432,000.0 | 413,842,000.0 |
| TNGX Tango Therapeutics Inc | 66,385,000.0 | 346,538,000.0 | 402,567,000.0 |
| ERAS Erasca Inc | 93,075,000.0 | 320,676,000.0 | 395,297,000.0 |
| GERN Geron Corp | 70,023,000.0 | 341,348,000.0 | 394,076,000.0 |
| JANX Janux Therapeutics Inc | 19,205,000.0 | 349,241,000.0 | 380,407,000.0 |
| NKTX Nkarta Inc | 31,040,000.0 | 253,071,000.0 | 378,885,000.0 |
| CCCC C4 Therapeutics Inc | 126,590,000.0 | 271,189,000.0 | 376,451,000.0 |
| DAWN Day One Biopharmaceuticals Inc | 230,784,000.0 | 375,274,000.0 | 376,048,000.0 |
| AUTL Autolus Therapeutics PLC | 239,566,000.0 | 275,302,000.0 | 375,381,000.0 |
| KROS Keros Therapeutics Inc | 331,147,000.0 | 347,293,000.0 | 370,025,000.0 |
| MCRB Seres Therapeutics Inc | 127,965,000.0 | 175,410,000.0 | 358,600,000.0 |
| PTGX Protagonist Therapeutics Inc | 186,727,000.0 | 355,577,000.0 | 357,951,000.0 |
| EYPT EyePoint Pharmaceuticals Inc | 281,263,000.0 | 344,800,000.0 | 355,184,000.0 |
| KMDA Kamada Ltd | 55,641,000.0 | 169,962,000.0 | 354,907,000.0 |
| ADCT ADC Therapeutics SA | 278,598,000.0 | 336,291,000.0 | 354,782,000.0 |
| VCEL Vericel Corp | 69,088,000.0 | 205,631,000.0 | 353,657,000.0 |
| VYGR Voyager Therapeutics Inc | 68,802,000.0 | 319,684,000.0 | 351,281,000.0 |
| ARQT Arcutis Biotherapeutics Inc | 88,398,000.0 | 330,431,000.0 | 341,365,000.0 |
| EWTX Edgewise Therapeutics Inc | 86,097,000.0 | 326,997,000.0 | 340,035,000.0 |
| RYTM Rhythm Pharmaceuticals Inc | 60,081,000.0 | 308,268,000.0 | 332,745,000.0 |
| TGTX TG Therapeutics Inc | 92,933,000.0 | 317,943,000.0 | 329,587,000.0 |
| ADMA ADMA Biologics Inc | 51,352,000.0 | 257,013,000.0 | 329,182,000.0 |
| MGTX MeiraGTx Holdings PLC | 129,566,000.0 | 159,622,000.0 | 326,744,000.0 |
| TIL Instil Bio Inc | 9,195,000.0 | 160,759,000.0 | 325,630,000.0 |
| AGEN Agenus Inc | 76,110,000.0 | 112,416,000.0 | 313,913,000.0 |
| COGT Cogent Biosciences Inc | 53,229,000.0 | 270,771,000.0 | 313,437,000.0 |
| NRIX Nurix Therapeutics Inc | 49,813,000.0 | 250,969,000.0 | 312,674,000.0 |
| GOSS Gossamer Bio Inc | 32,109,000.0 | 306,519,000.0 | 311,916,000.0 |
| SRRK Scholar Rock Holding Corp | 101,855,000.0 | 288,194,000.0 | 311,035,000.0 |
| ABOS Acumen Pharmaceuticals Inc | 66,886,000.0 | 246,615,000.0 | 310,125,000.0 |
| VRNA Verona Pharma PLC | 271,772,000.0 | 289,708,000.0 | 308,124,000.0 |
| INBX Inhibrx Inc | 277,924,000.0 | 295,358,000.0 | 307,893,000.0 |
| GLUE Monte Rosa Therapeutics Inc | 128,101,000.0 | 236,212,000.0 | 303,755,000.0 |
| MGNX MacroGenics Inc | 100,956,000.0 | 251,339,000.0 | 298,418,000.0 |
| ANNX Annexon Inc | 225,110,000.0 | 263,860,000.0 | 297,674,000.0 |
| DSGN Design Therapeutics Inc | 21,200,000.0 | 284,584,000.0 | 289,643,000.0 |
| NAUT Nautilus Biotechnology Inc | 25,729,000.0 | 185,094,000.0 | 288,650,000.0 |
| ADAP Adaptimmune Therapeutics PLC | 143,991,000.0 | 207,552,000.0 | 282,616,000.0 |
| VTYX Ventyx Biosciences Inc | 51,579,000.0 | 264,345,000.0 | 277,693,000.0 |
| OLMA Olema Pharmaceuticals Inc | 68,539,000.0 | 266,513,000.0 | 276,945,000.0 |
| WVE WAVE Life Sciences Ltd | 200,351,000.0 | 235,373,000.0 | 274,949,000.0 |
| PSTX Poseida Therapeutics Inc | 44,472,000.0 | 226,475,000.0 | 273,885,000.0 |
| TCRX TScan Therapeutics Inc | 133,359,000.0 | 194,237,000.0 | 272,149,000.0 |
| ANIK Anika Therapeutics Inc | 72,867,000.0 | 163,309,000.0 | 270,632,000.0 |
| TERN Terns Pharmaceuticals Inc | 79,926,000.0 | 267,432,000.0 | 268,517,000.0 |
| MXCT MaxCyte Inc | 46,506,000.0 | 190,194,000.0 | 268,274,000.0 |
| TARS Tarsus Pharmaceuticals Inc | 224,947,000.0 | 256,131,000.0 | 265,491,000.0 |
| FULC Fulcrum Therapeutics Inc | 25,563,000.0 | 242,199,000.0 | 257,694,000.0 |
| AURA Aura Biosciences Inc | 41,063,000.0 | 231,794,000.0 | 255,075,000.0 |
| ATXS Astria Therapeutics Inc | 175,530,000.0 | 250,942,000.0 | 254,666,000.0 |
| RPTX Repare Therapeutics Inc | 111,268,000.0 | 243,688,000.0 | 253,901,000.0 |
| CABA Cabaletta Bio Inc | 193,238,000.0 | 244,490,000.0 | 253,650,000.0 |
| ORIC Oric Pharmaceuticals Inc | 23,384,000.0 | 212,597,000.0 | 252,007,000.0 |
| ALLK Allakos Inc | 66,440,000.0 | 179,889,000.0 | 243,610,000.0 |
| ALXO ALX Oncology Holdings Inc | 22,406,000.0 | 188,659,000.0 | 242,553,000.0 |
| MDXG MiMedx Group Inc | 82,000,000.0 | 164,261,000.0 | 239,047,000.0 |
| XOMA XOMA Corp | 153,290,000.0 | 169,313,000.0 | 234,301,000.0 |
| PBYI Puma Biotechnology Inc | 84,585,000.0 | 156,185,000.0 | 230,528,000.0 |
| LXRX Lexicon Pharmaceuticals Inc | 22,465,000.0 | 176,547,000.0 | 229,429,000.0 |
| STOK Stoke Therapeutics Inc | 191,442,000.0 | 215,339,000.0 | 228,342,000.0 |
| XBIT XBiotech Inc | 200,023,000.0 | 201,718,000.0 | 226,615,000.0 |
| GHRS GH Research PLC | 78,420,000.0 | 164,089,000.0 | 226,300,000.0 |
| MRSN Mersana Therapeutics Inc | 174,561,000.0 | 214,057,000.0 | 226,060,000.0 |
| TYRA Tyra Biosciences Inc | 58,006,000.0 | 211,671,000.0 | 225,857,000.0 |
| KZR Kezar Life Sciences Inc | 35,493,000.0 | 206,950,000.0 | 221,235,000.0 |
| ABSI Absci Corp | 72,362,000.0 | 120,578,000.0 | 217,298,000.0 |
| BNGO Bionano Genomics Inc | 17,948,000.0 | 140,118,000.0 | 214,404,000.0 |
| KRON Kronos Bio Inc | 64,326,000.0 | 178,778,000.0 | 213,279,000.0 |
| CMRX Chimerix Inc | 27,661,000.0 | 189,110,000.0 | 212,774,000.0 |
| ACET Adicet Bio Inc | 159,711,000.0 | 162,272,000.0 | 207,295,000.0 |
| OMGA Omega Therapeutics Inc | 68,443,000.0 | 89,884,000.0 | 204,366,000.0 |
| CTMX CytomX Therapeutics Inc | 17,171,000.0 | 182,936,000.0 | 201,792,000.0 |
| INZY Inozyme Pharma Inc | 34,588,000.0 | 196,250,000.0 | 200,847,000.0 |
| BMEA Biomea Fusion Inc | 176,866,000.0 | 179,181,000.0 | 199,927,000.0 |
| VOR Vor Biopharma Inc | 31,360,000.0 | 140,803,000.0 | 198,126,000.0 |
| IKNA Ikena Oncology Inc | 119,894,000.0 | 178,662,000.0 | 192,092,000.0 |
| CELC Celcuity Inc | 30,662,770.0 | 190,590,600.0 | 191,219,400.0 |
| AQB AquaBounty Technologies Inc | 8,203,870.0 | 11,637,750.0 | 187,551,430.0 |
| DBVT Dbv Technologies SA | 141,367,000.0 | 158,915,000.0 | 182,986,000.0 |
載入數據中...
最新要聞
和生物製藥相關的產業概念股
生物製藥概念股相關指標排名
生物製藥每月營收
生物製藥每股盈餘
生物製藥每股淨值
生物製藥損益表
生物製藥總資產
生物製藥負債和股東權益
生物製藥現金流量表
生物製藥利潤比率
生物製藥營業費用率拆解
生物製藥杜邦分析
生物製藥ROE / ROA
生物製藥經營週轉能力
生物製藥營運週轉天數
生物製藥現金股利發放率
生物製藥財務結構比率
生物製藥流速動比率
生物製藥利息保障倍數
生物製藥現金流量分析
生物製藥營業現金流對淨利比
生物製藥盈餘再投資比率
生物製藥月營收成長率
生物製藥營收成長率
生物製藥毛利成長率
生物製藥營業利益成長率
生物製藥稅後淨利成長率
生物製藥每股盈餘成長率
生物製藥本益比評價
生物製藥股價淨值比評價
生物製藥現金股利殖利率
生物製藥平均現金股息殖利率
生物製藥董監持股比例
生物製藥董監持股質押比例